INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "TUMOR-TARGETED SPLIT IL12 RECEPTOR AGONISTS"

GENEVA, Dec. 2 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, NY 10591) filed a patent application (PCT/US2025/030852) for "TUMOR-TARGETED SPLIT IL12 RECEPTOR AGONISTS" on May 23, 2025. With publication no. WO/2025/245494, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Jiaxi (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591), CHANG, Aaron (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591), D'ORVILLIERS, Amanda (c/o Regeneron ...